Related Experiment Videos

Multiple changes of penicillin-binding proteins in penicillin-resistant clinical isolates of Streptococcus pneumoniae

Insights

Penicillin resistance in Streptococcus pneumoniae involves decreased penicillin-binding protein (PBP) affinity and the emergence of a new PBP (PBP 2'). PBP 3 remains unaffected, retaining high penicillin affinity.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Streptococcus pneumoniae is a significant human pathogen.
  • Penicillin resistance in S. pneumoniae is a growing public health concern.
  • Penicillin-binding proteins (PBPs) are the primary targets of beta-lactam antibiotics like penicillin.

Purpose of the Study:

  • To investigate the penicillin-binding properties of PBPs in clinical isolates of S. pneumoniae with varying penicillin susceptibilities.
  • To characterize the changes in PBPs associated with the development of penicillin resistance.

Main Methods:

  • Comparative analysis of penicillin-binding affinities in whole cells, isolated membranes, and specific PBPs.
  • In vivo and in vitro labeling techniques were employed.
  • Susceptibility testing using minimal inhibitory concentration (MIC) was performed.

Main Results:

  • Decreased relative affinity to penicillin was observed in whole cells, isolated membranes, and two major PBPs as penicillin resistance increased.
  • A novel PBP, designated PBP 2', emerged in S. pneumoniae strains with higher levels of penicillin resistance (MIC ≥ 0.25 µg/ml).
  • PBP 3 consistently demonstrated high affinity for penicillin across all tested strains and conditions.

Conclusions:

  • The development of penicillin resistance in S. pneumoniae is associated with alterations in PBP penicillin-binding affinity.
  • The appearance of PBP 2' is a key characteristic of relatively penicillin-resistant strains.
  • PBP 3's conserved high affinity suggests it is not a primary factor in penicillin resistance in these isolates.

Related Concept Videos